FindTrial
Sign In

minimally invasive surgery for bile duct cancer

Comparison of survival for patients who underwent minimally invasive and open surgery for distal common bile duct cancer : Propensity score matched analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007112
Enrollment
429
Registered
2022-03-24
Start date
2021-06-08
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients who underwent pancreaticoduodenectomy for distal bile duct cancer

Exclusion criteria

Exclusion criteria: The patients with other malignancies incomplete medical records

Design outcomes

Primary

MeasureTime frame
3 year survival rate—

Secondary

MeasureTime frame
3 years recurrence free survival rate—

Countries

Korea, Republic of

Contacts

Public ContactSongCheol Kim

Asan Medical Center

drksc@amc.seoul.kr+82-2-3010-3936

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026